We aimed to: (1) explore the effect of oral potassium supplementation on urinary potassium excretion, and (2) evaluate the value of urinary potassium-related indicators in distinguishing primary aldos
Supplemental Table 1. Summary of the included clinical prediction models and the guideline-based prediction rule. Supplemental Figure 1. Frequency of predictor variables used in the included clinical
ABSTRACT Primary aldosteronism (PA) is the most common form of secondary hypertension (HTN), with an estimated prevalence of 4% of hypertensive patients in primary care and around 10% of referred pati
